Forecast

There is no analyst data available for this company.

News Go to news feed

Origin Agritech shifts strategy to proprietary maize seed

Origin Agritech announced in Q2 FY2026 a strategic shift to direct sales of proprietary maize seed products, accompanied by significant cost reductions and an expansion of breeding programs including recognition of the gene‑editing platform Hi3. Revenue fell 31.9% to RMB 49.2 million, gross margin remained stable, operating expenses were cut by 43.9%, and net loss improved by 43.8% to RMB 14.4 million. Management expects further focus on proprietary products and biotechnological advances with revenue projections of USD 13.43 million for 2026/2027. Risks remain in near‑term revenue momentum, higher liabilities and potential regulatory uncertainties around GMO commercialization. » More on de.investing.com
Origin Agritech appoints Dr. Jian Zhang to board and reappoints Dr. Zheng James Chen as CFO

Origin Agritech named Dr. Jian Zhang as an independent board member and confirmed Dr. Zheng James Chen as Chief Financial Officer effective March 20. The personnel moves come against a backdrop of revenue falling 35% to USD 47.8 million and a negative EBITDA of USD 27.1 million. Despite the earnings hit, the stock has risen 61% year-to-date and trades at USD 1.90 (market capitalization USD 9.4 million); according to InvestingPro, cash exceeds debt and liquid assets exceed current liabilities. At the same time, Dr. Changqing Mao resigned as an independent director, and earlier Chi Kin (Patrick) Cheng stepped down as CFO. » More on de.investing.com
Origin Agritech: Hi3-gen-editing in China recognized as scientific breakthrough

The Chinese Academy of Agricultural Sciences selected Origin Agritech’s Hi3‑gen‑editing technology for haploid maize induction lines as one of the ten most important agricultural science advances of 2025. The method, developed with Hainan Aoyu Biotech and China Agricultural University, is said to improve maize inbred lines to high-yield performance within one year and save three to four years compared with conventional breeding. Origin reports initial field trials with yield increases, is pursuing commercialization and benefits from accelerated biosafety approvals in China. Financial weaknesses remain: revenue decline, negative EBITDA, low current ratio and tight cash reserves despite fresh capital injections and licensing agreements. » More on de.investing.com

Financials

In the last quarter, Origin Agritech had revenue of 880.21k€ and net profit of −257.06k€

(EUR)	Mar 2026	YoY
Revenue	+880.21k	-
Gross profit	+98.45k	-
Net profit	−257.06k	-
EBITDA	−230.18k	-

Fundamentals

Metric	Value
Market capitalization	+10.27m€
Number of shares	12.13m
52-week high/low	+2,14€ - +0,75€
Dividends	No
Beta	1,54
P/E ratio	−1,07
PEG ratio	+0,01
P/B ratio	−1,32
P/S ratio	+1,14

Company profile

Origin Agritech Limited betreibt zusammen mit seinen Tochtergesellschaften eine landwirtschaftliche Biotechnologie- und eine E-Commerce-Plattform in der Volksrepublik China. Das Unternehmen ist im Bereich der Saatgutzüchtung und genetischen Verbesserung tätig. Es entwickelt, produziert und vertreibt Hybridsaatgut und entwickelt Technologien für Hybridsaatgut. Das Unternehmen betreibt auch eine E-Commerce-Plattform, die Landwirten über Online- und Mobilbestellungen eine Reihe von Produkten anbietet, darunter landwirtschaftliche Saatgutprodukte wie Mais-, Reis- und Gemüsesaatgut, andere landwirtschaftliche Betriebsmittel wie Düngemittel und Agrarchemikalien, Lebensmittel, Haushaltsprodukte und andere Verbraucherprodukte. Das Unternehmen arbeitet mit der Chinesischen Akademie für Agrarwissenschaften, dem National Maize Improvement Center, der China Agricultural University und der Zhejiang University zusammen. Origin Agritech Limited wurde 1997 gegründet und hat seinen Hauptsitz in Peking, China.

Name	Origin Agritech
CEO	Weibin Yan
Headquarters	Beijing, be Virgin Islands (British)
Website	originseed.com.cn
Sector	Consumer Staples
Industry	Food Products
IPO	03/29/2004
Employees	97